Abstract
Phosphatidylinositol-3-kinases (PI3K) control many aspects of cellular activation and differentiation and play an important role in B cells biology. Three different classes of PI3K have been described, all of which are expressed in B cells. However, it is the class IA PI3Ks, and the p110δ catalytic subunit in particular, which seem to play the most critical role in B cells. Here we discuss the important role that class IA PI3K plays in B cell development, activation and differentiation, as well as examine what is known about the other classes of PI3Ks in B cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- AID:
-
Activation-induced cytidine deaminase protein
- BCR:
-
B cell receptor
- DZ:
-
Dark zone
- FOXO:
-
Forkhead box O
- GCs:
-
Germinal centres
- GOF:
-
Gain of function
- Ig:
-
Immunoglobulin
- LOF:
-
Loss of function
- LZ:
-
Light zone
- mTORC1:
-
Mechanistic target of rapamycin complex 1
- mTORC2:
-
Mechanistic target of rapamycin complex 2
- MZ:
-
Marginal Zone
- PDK1:
-
Phosphoinositide-dependent kinase-1
- PI3K:
-
Phosphatidylinositol-3-kinase
- PI-(4,5)-P2:
-
Phosphatidylinositol-(4,5)-biphosphate
- PIP3:
-
Phosphatidylinositol-(3,4,5)-trisphosphate
- PTEN:
-
Phosphatase and tensin homolog deleted on chromosome ten
- RAG1:
-
Recombination-activating genes 1
- RAG2:
-
Recombination-activating genes 2
- SHIP:
-
SH2-domain containing inositol-5-phosphatases
- TD:
-
T dependent
- TI:
-
T independent
References
Abdelsamed HA, Desai M, Nance SC, Fitzpatrick EA (2011) T-bet controls severity of hypersensitivity pneumonitis. J Inflamm (lond) 8(1):15
Akerlund J, Getahun A, Cambier JC (2015) B cell expression of the SH2-containing inositol 5-phosphatase (SHIP-1) is required to establish anergy to high affinity, proteinacious autoantigens. J Autoimmun 62:45–54
Ali AY, Wu X, Eissa N, Hou S, Ghia JE, Murooka TT et al (2018) Distinct roles for phosphoinositide 3-kinases gamma and delta in malignant B cell migration. Leukemia 32(9):1958–1969
Alliouachene S, Bilanges B, Chicanne G, Anderson KE, Pearce W, Ali K et al (2015) Inactivation of the class II PI3K-C2beta potentiates insulin signaling and sensitivity. Cell Rep 13(9):1881–1894
Amin RH, Schlissel MS (2008) Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat Immunol 9(6):613–622
Angulo I, Vadas O, Garçon F, Banham-Hall E, Plagnol V, Leahy TR et al (2013) Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage. Science 342(6160):866–871
Anzelon AN, Wu H, Rickert RC (2003) Pten inactivation alters peripheral B lymphocyte fate and reconstitutes CD19 function. Nat Immunol 4(3):287–294
Attridge K, Kenefeck R, Wardzinski L, Qureshi OS, Wang CJ, Manzotti C et al (2014) IL-21 promotes CD4 T cell responses by phosphatidylinositol 3-kinase-dependent upregulation of CD86 on B cells. J Immunol 192(5):2195–2201
Avery DT, Kane A, Nguyen T, Lau A, Nguyen A, Lenthall H et al (2018) Germline-activating mutations in PIK3CD compromise B cell development and function. J Exp Med 215(8):2073–2095
Backer JM (2016) The intricate regulation and complex functions of the Class III phosphoinositide 3-kinase Vps34. Biochem J 473(15):2251–2271
Beer-Hammer S, Zebedin E, von Holleben M, Alferink J, Reis B, Dresing P et al (2010) The catalytic PI3K isoforms p110gamma and p110delta contribute to B cell development and maintenance, transformation, and proliferation. J Leukoc Biol 87(6):1083–1095
Bier J, Rao G, Payne K, Brigden H, French E, Pelham SJ et al (2019) Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4(+) T cells. J Allergy Clin Immunol 144(1):236–253
Bilancio A, Okkenhaug K, Camps M, Emery JL, Ruckle T, Rommel C et al (2006) Key role of the p110delta isoform of PI3K in B-cell antigen and IL-4 receptor signaling: comparative analysis of genetic and pharmacologic interference with p110delta function in B cells. Blood 107(2):642–650
Bilanges B, Posor Y, Vanhaesebroeck B (2019) PI3K isoforms in cell signalling and vesicle trafficking. Nat Rev Mol Cell Biol 20(9):515–534
Brink R, Phan TG (2018) Self-reactive B cells in the germinal center reaction. Annu Rev Immunol 36(1):339–357
Browne CD, Del Nagro CJ, Cato MH, Dengler HS, Rickert RC (2009) Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy. Immunity 31(5):749–760
Calamito M, Juntilla MM, Thomas M, Northrup DL, Rathmell J, Birnbaum MJ et al (2010) Akt1 and Akt2 promote peripheral B-cell maturation and survival. Blood 115(20):4043–4050
Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA et al (2018) Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med 24(5):679–690
Chen J, Limon JJ, Blanc C, Peng SL, Fruman DA (2010) Foxo1 regulates marginal zone B-cell development. Eur J Immunol 40(7):1890–1896
Chen Z, Getahun A, Chen X, Dollin Y, Cambier JC, Wang JH (2015) Imbalanced PTEN and PI3K signaling impairs class switch recombination. J Immunol 195(11):5461–5471
Cheng S, Hsia CY, Feng B, Liou M-L, Fang X, Pandolfi PP et al (2009) BCR-mediated apoptosis associated with negative selection of immature B cells is selectively dependent on Pten. Cell Res 19(2):196–207
Clark MR, Mandal M, Ochiai K, Singh H (2014) Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling. Nat Rev Immunol 14(2):69–80
Clayton E, Bardi G, Bell SE, Chantry D, Downes CP, Gray A et al (2002) A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation. J Exp Med 196(6):753–763
Cohen SB, Bainter W, Johnson JL, Lin T-Y, Wong JCY, Wallace JG et al (2019) Human primary immunodeficiency caused by expression of a kinase-dead p110δ mutant. J Allergy Clin Immunol 143(2):797-799.e2
Conley ME, Dobbs AK, Quintana AM, Bosompem A, Wang Y-D, Coustan-Smith E et al (2012) Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K. J Exp Med 209(3):463–470
Coulter TI, Chandra A, Bacon CM, Babar J, Curtis J, Screaton N et al (2017) Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study. J Allergy Clin Immunol 139(2):597-606.e4
Deau MC, Heurtier L, Frange P, Suarez F, Bole-Feysot C, Nitschke P, Cavazzana M, Picard C, Durandy A, Fischer A, Kracker S (2014) A human immunodeficiency caused by mutations in the PIK3R1 gene. J Clin Invest 124(9):3923–3928. https://doi.org/10.1172/JCI75746
Dengler HS, Baracho GV, Omori SA, Bruckner S, Arden KC, Castrillon DH et al (2008) Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nat Immunol 9(12):1388–1398
Dil N, Marshall AJ (2009) Role of phosphoinositide 3-kinase p110 delta in TLR4- and TLR9-mediated B cell cytokine production and differentiation. Mol Immunol 46(10):1970–1978
Dominguez-Sola D, Kung J, Holmes AB, Wells VA, Mo T, Basso K et al (2015) The FOXO1 transcription factor instructs the germinal center dark zone program. Immunity
Donahue AC, Hess KL, Ng KL, Fruman DA (2004) Altered splenic B cell subset development in mice lacking phosphoinositide 3-kinase p85alpha. Int Immunol 16(12):1789–1798
Dulau Florea AE, Braylan RC, Schafernak KT, Williams KW, Daub J, Goyal RK et al (2017) Abnormal B-cell maturation in the bone marrow of patients with germline mutations in PIK3CD. J Allergy Clin Immunol 139(3):1032–1035 e6
Durandy A, Kracker S (2020) Increased activation of PI3 kinase-δ predisposes to B-cell lymphoma. Blood 135(9):638–643
Elkaim E, Neven B, Bruneau J, Mitsui-Sekinaka K, Stanislas A, Heurtier L et al (2016) Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: a cohort study. J Allergy Clin Immunol 138(1):210-218.e9
Fruman DA, Rommel C (2014) PI3K and cancer: lessons, challenges and opportunities. Nat Rev Drug Discov 13(2):140–156
Fruman DA, Snapper SB, Yballe CM, Davidson L, Yu JY, Alt FW et al (1999) Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85alpha. Science 283(5400):393–397
Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT (2017) The PI3K pathway in human disease. Cell 170(4):605–635
Getahun A, Beavers NA, Larson SR, Shlomchik MJ, Cambier JC (2016) Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells. J Exp Med 213(5):751–769
Goodnow CC, Sprent J, Fazekas de St Groth B, Vinuesa CG (2005) Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435(7042):590–597
Greaves SA, Peterson JN, Strauch P, Torres RM, Pelanda R (2019) Active PI3K abrogates central tolerance in high-avidity autoreactive B cells. J Exp Med 216(5):1135–1153
Harada K, Truong AB, Cai T, Khavari PA (2005) The class II phosphoinositide 3-kinase C2beta is not essential for epidermal differentiation. Mol Cell Biol 25(24):11122–11130
Harris DP, Vogel P, Wims M, Moberg K, Humphries J, Jhaver KG et al (2011) Requirement for class II phosphoinositide 3-kinase C2alpha in maintenance of glomerular structure and function. Mol Cell Biol 31(1):63–80
Herzog S, Hug E, Meixlsperger S, Paik J-H, DePinho RA, Reth M et al (2008) SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway. Nat Immunol 9(6):623–631
Hirsch E, Katanaev VL, Garlanda C, Azzolino O, Pirola L, Silengo L et al (2000) Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287(5455):1049–1053
Inoue T, Shinnakasu R, Ise W, Kawai C, Egawa T, Kurosaki T (2017) The transcription factor Foxo1 controls germinal center B cell proliferation in response to T cell help. J Exp Med 214(4):1181–1198
Iwata TN, Ramírez JA, Tsang M, Park H, Margineantu DH, Hockenbery DM et al (2016) Conditional disruption of raptor reveals an essential role for mTORC1 in B cell development, survival, and metabolism. J Immunol 197(6):2250–2260
Iwata TN, Ramírez-Komo JA, Park H, Iritani BM (2017) Control of B lymphocyte development and functions by the mTOR signaling pathways. Cytokine Growth Factor Rev 35:47–62
Janas ML, Hodson D, Stamataki Z, Hill S, Welch K, Gambardella L et al (2008) The effect of deleting p110delta on the phenotype and function of PTEN-deficient B cells. J Immunol 180(2):739–746
Jellusova J, Rickert RC (2016) The PI3K pathway in B cell metabolism. Crit Rev Biochem Mol Biol 51(5):359–378
Jellusova J, Miletic AV, Cato MH, Lin W-W, Hu Y, Bishop GA et al (2013) Context-specific BAFF-R signaling by the NF-κB and PI3K pathways. Cell Rep 5(4):1022–1035
Jou ST, Carpino N, Takahashi Y, Piekorz R, Chao JR, Carpino N et al (2002) Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex. Mol Cell Biol 22(24):8580–8591
Kracker S, Curtis J, Ibrahim MAA, Sediva A, Salisbury J, Campr V et al (2014) Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase δ syndrome. J Allergy Clin Immunol 134(1):233–236
Lau A, Avery DT, Jackson K, Lenthall H, Volpi S, Brigden H et al (2020) Activated PI3Kdelta breaches multiple B cell tolerance checkpoints and causes autoantibody production. J Exp Med 217(2):45
Limon JJ, Fruman DA (2012) Akt and mTOR in B cell activation and differentiation. Front Immunol 3:228
Llorian M, Stamataki Z, Hill S, Turner M, Mårtensson I-L (2007) The PI3K p110delta is required for down-regulation of RAG expression in immature B cells. J Immunol 178(4):1981–1985
Love C, Sun Z, Jima D, Li G, Zhang J, Miles R et al (2012) The genetic landscape of mutations in Burkitt lymphoma. Nat Genet 44(12):1321–1325
Lucas CL, Kuehn HS, Zhao F, Niemela JE, Deenick EK, Palendira U et al (2014a) Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency. Nat Immunol 15(1):88–97
Lucas CL, Zhang Y, Venida A, Wang Y, Hughes J, McElwee J et al (2014b) Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K. J Exp Med 211(13):2537–2547
Maccari ME, Abolhassani H, Aghamohammadi A, Aiuti A, Aleinikova O, Bangs C et al (2018) Disease evolution and response to rapamycin in activated phosphoinositide 3-Kinase δ syndrome: the European society for immunodeficiencies-activated phosphoinositide 3-Kinase δ syndrome registry. Front Immunol 9:543
Manning BD, Toker A (2017) AKT/PKB signaling: navigating the network. Cell 169(3):381–405
McLeod IX, Zhou X, Li QJ, Wang F, He YW (2011) The class III kinase Vps34 promotes T lymphocyte survival through regulating IL-7Ralpha surface expression. J Immunol 187(10):5051–5061
Monaco G, Lee B, Xu W, Mustafah S, Hwang YY, Carre C et al (2019) RNA-Seq signatures normalized by mRNA abundance allow absolute deconvolution of human immune cell types. Cell Rep 26(6):1627–1640 e7
Nemazee D (2017) Mechanisms of central tolerance for B cells. Nat Rev Immunol 17(5):281–294
Nombela-Arrieta C, Lacalle RA, Montoya MC, Kunisaki Y, Megias D, Marques M et al (2004) Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing. Immunity 21(3):429–441
Okkenhaug K (2013) Signaling by the phosphoinositide 3-kinase family in immune cells. Annu Rev Immunol 31:675–704
Okkenhaug K, Bilancio A, Farjot G, Priddle H, Sancho S, Peskett E et al (2002) Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science 297(5583):1031–1034
Okkenhaug K, Ali K, Vanhaesebroeck B (2007) Antigen receptor signalling: a distinctive role for the p110delta isoform of PI3K. Trends Immunol 28(2):80–87
Omori SA, Cato MH, Anzelon-Mills A, Puri KD, Shapiro-Shelef M, Calame K et al (2006) Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling. Immunity 25(4):545–557
O’Neill SK, Getahun A, Gauld SB, Merrell KT, Tamir I, Smith MJ et al (2011) Monophosphorylation of CD79a and CD79b ITAM motifs initiates a SHIP-1 phosphatase-mediated inhibitory signaling cascade required for B cell anergy. Immunity 35(5):746–756
Parekh VV, Wu L, Boyd KL, Williams JA, Gaddy JA, Olivares-Villagomez D et al (2013) Impaired autophagy, defective T cell homeostasis, and a wasting syndrome in mice with a T cell-specific deletion of Vps34. J Immunol 190(10):5086–5101
Petrovski S, Parrott RE, Roberts JL, Huang H, Yang J, Gorentla B et al (2016) Dominant splice site mutations in PIK3R1 cause hyper IgM syndrome, lymphadenopathy and short stature. J Clin Immunol 36(5):462–471
Pfeifer M, Grau M, Lenze D, Wenzel S-S, Wolf A, Wollert-Wulf B et al (2013) PTEN loss defines a PI3K/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A 110(30):12420–12425
Pillai S, Cariappa A (2009) The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev Immunol 9(11):767–777
Preite S, Cannons JL, Radtke AJ, Vujkovic-Cvijin I, Gomez-Rodriguez J, Volpi S et al (2018) Hyperactivated PI3Kδ promotes self and commensal reactivity at the expense of optimal humoral immunity. Nat Immunol 19(9):986–1000
Psyrri A, Papageorgiou S, Liakata E, Scorilas A, Rontogianni D, Kontos CK et al (2009) Phosphatidylinositol 3’-kinase catalytic subunit alpha gene amplification contributes to the pathogenesis of mantle cell lymphoma. Clin Cancer Res 15(18):5724–5732
Ramadani F, Bolland DJ, Garcon F, Emery JL, Vanhaesebroeck B, Corcoran AE et al (2010) The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development. Sci Signal 3(134):ra60
Reif K, Cyster JG (2000) RGS molecule expression in murine B lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines. J Immunol 164(9):4720–4729
Reif K, Okkenhaug K, Sasaki T, Penninger JM, Vanhaesebroeck B, Cyster JG (2004) Cutting edge: differential roles for phosphoinositide 3-kinases, p110gamma and p110delta, in lymphocyte chemotaxis and homing. J Immunol 173(4):2236–2240
Ren CL, Morio T, Fu SM, Geha RS (1994) Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase C gamma 2. J Exp Med 179(2):673–680
Rickert RC (2013) New insights into pre-BCR and BCR signalling with relevance to B cell malignancies. Nat Rev Immunol 13(8):578–591
Rolf J, Bell SE, Kovesdi D, Janas ML, Soond DR, Webb LM et al (2010) Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction. J Immunol 185(7):4042–4052
Sander S, Calado DP, Srinivasan L, Köchert K, Zhang B, Rosolowski M et al (2012) Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis. Cancer Cell 22(2):167–179
Sander S, Chu VT, Yasuda T, Franklin A, Graf R, Calado DP et al (2015) PI3 Kinase and FOXO1 transcription factor activity differentially control B cells in the germinal center light and dark zones. Immunity 43(6):1075–1086
Sasaki T, Irie-Sasaki J, Jones RG, Oliveira-dos-Santos AJ, Stanford WL, Bolon B et al (2000) Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 287(5455):1040–1046
Schatz DG, Ji Y (2011) Recombination centres and the orchestration of V(D)J recombination. Nat Rev Immunol 11(4):251–263
Schmiedel BJ, Singh D, Madrigal A, Valdovino-Gonzalez AG, White BM, Zapardiel-Gonzalo J et al (2018) Impact of genetic polymorphisms on human immune cell gene expression. Cell 175(6):1701–1715 e16
Setz CS, Khadour A, Renna V, Iype J, Gentner E, He X et al (2019) Pten controls B-cell responsiveness and germinal center reaction by regulating the expression of IgD BCR. EMBO J 38(11)
Sharfe N, Karanxha A, Dadi H, Merico D, Chitayat D, Herbrick JA et al (2018) Dual loss of p110delta PI3-kinase and SKAP (KNSTRN) expression leads to combined immunodeficiency and multisystem syndromic features. J Allergy Clin Immunol 142(2):618–629
Smith MJ, Ford BR, Rihanek M, Coleman BM, Getahun A, Sarapura VD et al (2019) Elevated PTEN expression maintains anergy in human B cells and reveals unexpectedly high repertoire autoreactivity. JCI Insight 4(3)
Sogkas G, Fedchenko M, Dhingra A, Jablonka A, Schmidt RE, Atschekzei F (2018) Primary immunodeficiency disorder caused by phosphoinositide 3-kinase δ deficiency. J Allergy Clin Immunol 142(5):1650-1653.e2
Srinivasan L, Sasaki Y, Calado DP, Zhang B, Paik JH, DePinho RA et al (2009) PI3 kinase signals BCR-dependent mature B cell survival. Cell 139(3):573–586
Srivastava S, Cai X, Li Z, Sun Y, Skolnik EY (2012) Phosphatidylinositol-3-kinase C2beta and TRIM27 function to positively and negatively regulate IgE receptor activation of mast cells. Mol Cell Biol 32(15):3132–3139
Srivastava S, Li Z, Skolnik EY (2017) Phosphatidlyinositol-3-kinase C2 beta (PI3KC2beta) is a potential new target to treat IgE mediated disease. PLoS ONE 12(8):e0183474
Srivastava S, Di L, Zhdanova O, Li Z, Vardhana S, Wan Q et al (2009) The class II phosphatidylinositol 3 kinase C2beta is required for the activation of the K+ channel KCa3.1 and CD4 T-cells. Mol Biol Cell 20(17):3783–3791
Stark A-K, Chandra A, Chakraborty K, Alam R, Carbonaro V, Clark J et al (2018) PI3Kδ hyper-activation promotes development of B cells that exacerbate Streptococcus pneumoniae infection in an antibody-independent manner. Nat Commun 9(1):3174
Suzuki H, Terauchi Y, Fujiwara M, Aizawa S, Yazaki Y, Kadowaki T et al (1999) Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. Science 283(5400):390–392
Suzuki A, Kaisho T, Ohishi M, Tsukio-Yamaguchi M, Tsubata T, Koni PA et al (2003) Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination. J Exp Med 197(5):657–667
Takeda M, Ito W, Tanabe M, Ueki S, Kato H, Kihara J et al (2009) Allergic airway hyperresponsiveness, inflammation, and remodeling do not develop in phosphoinositide 3-kinase gamma-deficient mice. J Allergy Clin Immunol 123(4):805–812
Takeda AJ, Maher TJ, Zhang Y, Lanahan SM, Bucklin ML, Compton SR et al (2019) Human PI3Kgamma deficiency and its microbiota-dependent mouse model reveal immunodeficiency and tissue immunopathology. Nat Commun 10(1):4364
Tang P, Upton JEM, Barton-Forbes MA, Salvadori MI, Clynick MP, Price AK et al (2018) Autosomal Recessive Agammaglobulinemia Due to a Homozygous Mutation in PIK3R1. J Clin Immunol 38(1):88–95
Tangye SG, Bier J, Lau A, Nguyen T, Uzel G, Deenick EK (2019) Immune dysregulation and disease pathogenesis due to activating mutations in PIK3CD-the Goldilocks’ effect. J Clin Immunol 39(2):148–158
Thian M, Hoeger B, Kamnev A, Poyer F, Kostel Bal S, Caldera M et al (2020) Germline biallelic PIK3CG mutations in a multifaceted immunodeficiency with immune dysregulation. Haematologica 105(5):haematol.2019.231399-e488
Thorpe LM, Yuzugullu H, Zhao JJ (2015) PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting. Nat Rev Cancer 15(1):7–24
Tiosano D, Baris HN, Chen A, Hitzert MM, Schueler M, Gulluni F et al (2019) Mutations in PIK3C2A cause syndromic short stature, skeletal abnormalities, and cataracts associated with ciliary dysfunction. PLoS Genet 15(4):e1008088
Verkoczy L, Duong B, Skog P, Aït-Azzouzene D, Puri K, Vela JL et al (2007) Basal B cell receptor-directed phosphatidylinositol 3-kinase signaling turns off RAGs and promotes B cell-positive selection. J Immunol 178(10):6332–6341
von Keudell G, Moskowitz AJ (2019) The Role of PI3K inhibition in lymphoid malignancies. Curr Hematol Malig Rep 14(5):405–413
Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC (2003) Predominant autoantibody production by early human B cell precursors. Science 301(5638):1374–1377
Wentink M, Dalm V, Lankester AC, van Schouwenburg PA, Schölvinck L, Kalina T et al (2017) Genetic defects in PI3Kδ affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections. Clin Immunol 176:77–86
Willinger T, Flavell RA (2012) Canonical autophagy dependent on the class III phosphoinositide-3 kinase Vps34 is required for naive T-cell homeostasis. Proc Natl Acad Sci U S A 109(22):8670–8675
Winkler TH, Mårtensson I-L (2018) The role of the Pre-B cell receptor in B cell development, repertoire selection, and tolerance. Front Immunol 9:2423
Wray-Dutra MN, Al Qureshah F, Metzler G, Oukka M, James RG, Rawlings DJ (2018) Activated PIK3CD drives innate B cell expansion yet limits B cell-intrinsic immune responses. J Exp Med 215(10):2485–2496
Zaiss DMW, Coffer PJ (2018) Forkhead box transcription factors as context-dependent regulators of lymphocyte homeostasis. Nat Rev Immunol 18(11):703–715
Zhang J, Grubor V, Love CL, Banerjee A, Richards KL, Mieczkowski PA et al (2013) Genetic heterogeneity of diffuse large B-cell lymphoma. Proc Natl Acad Sci U S A 110(4):1398–1403
Zhang Y, Zhu G, Xiao H, Liu X, Han G, Chen G et al (2017) CD19 regulates ADAM28-mediated Notch2 cleavage to control the differentiation of marginal zone precursors to MZ B cells. J Cell Mol Med 21(12):3658–3669
Zhang TT, Okkenhaug K, Nashed BF, Puri KD, Knight ZA, Shokat KM et al (2008) Genetic or pharmaceutical blockade of p110delta phosphoinositide 3-kinase enhances IgE production. J Allergy Clin Immunol 122(4):811–819 e2
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Deenick, E.K., Bier, J., Lau, A. (2022). PI3K Isoforms in B Cells. In: Dominguez-Villar, M. (eds) PI3K and AKT Isoforms in Immunity . Current Topics in Microbiology and Immunology, vol 436. Springer, Cham. https://doi.org/10.1007/978-3-031-06566-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-031-06566-8_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-06565-1
Online ISBN: 978-3-031-06566-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)